BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10498107)

  • 1. Monitoring warfarin therapy.
    Beanland DR; Dorsey DA
    Am Fam Physician; 1999 Sep; 60(3):764, 766. PubMed ID: 10498107
    [No Abstract]   [Full Text] [Related]  

  • 2. A randomized trial comparing 1 mg of oral vitamin K with no treatment in the management of warfarin-associated coagulopathy in patients with mechanical heart valves.
    Ageno W; Garcia D; Silingardi M; Galli M; Crowther M
    J Am Coll Cardiol; 2005 Aug; 46(4):732-3. PubMed ID: 16098445
    [No Abstract]   [Full Text] [Related]  

  • 3. Warfarin and epistaxis: should warfarin always be discontinued?
    Srinivasan V; Patel H; John DG; Worsley A
    Clin Otolaryngol Allied Sci; 1997 Dec; 22(6):542-4. PubMed ID: 9466067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What to do when warfarin therapy goes too far.
    Prasad S; Wootten MR; Kulinski N; Chapman SA
    J Fam Pract; 2009 Jul; 58(7):346-52. PubMed ID: 19607771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical delay in acute admissions on warfarin: are we doing enough?
    Tharmarajah P
    Int J Clin Pract; 2007 Jul; 61(7):1233. PubMed ID: 17577302
    [No Abstract]   [Full Text] [Related]  

  • 6. Reversal of vitamin K antagonist-associated coagulopathy: a survey of current practice.
    Neal M; Crowther M; Douketis J; Verhovsek M; Stidley C; Garcia D
    Thromb Res; 2008; 122(6):864-6. PubMed ID: 18678398
    [No Abstract]   [Full Text] [Related]  

  • 7. Epistaxis in patients taking oral anticoagulant and antiplatelet medication: prospective cohort study.
    Smith J; Siddiq S; Dyer C; Rainsbury J; Kim D
    J Laryngol Otol; 2011 Jan; 125(1):38-42. PubMed ID: 20843406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Warfarin resistance and enteral tube feeding: a vitamin K-independent interaction.
    Dickerson RN
    Nutrition; 2008 Oct; 24(10):1048-52. PubMed ID: 18602249
    [No Abstract]   [Full Text] [Related]  

  • 9. An oral vitamin K protocol to reverse over-anticoagulation in patients presenting with an International Normalised Ratio above 10.0.
    Denas G; Cucchini U; Iliceto S; Pengo V
    Thromb Haemost; 2009 Feb; 101(2):410-1. PubMed ID: 19190831
    [No Abstract]   [Full Text] [Related]  

  • 10. Warfarin hypersensitivity due to gluten-sensitive enteropathy: a case study.
    Kwolek S; Deming P
    Clin Lab Sci; 2012; 25(2):78-80. PubMed ID: 22693776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poor correlation of supratherapeutic international normalised ratio and vitamin K-dependent procoagulant factor levels during warfarin therapy.
    Sarode R; Rawal A; Lee R; Shen YM; Frenkel EP
    Br J Haematol; 2006 Mar; 132(5):604-7. PubMed ID: 16445834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prothrombin complex concentrate good in warfarin induced hemorrhage. Quick reversal--plasma should be avoided].
    Själander A; Berntorp E; Svensson PJ
    Lakartidningen; 2009 Sep 9-15; 106(37):2278, 2280-1. PubMed ID: 19817161
    [No Abstract]   [Full Text] [Related]  

  • 13. The perioperative management of warfarin therapy.
    Ansell JE
    Arch Intern Med; 2003 Apr; 163(8):881-3. PubMed ID: 12719195
    [No Abstract]   [Full Text] [Related]  

  • 14. Multisite mucous membrane bleeding due to a possible interaction between warfarin and 5-fluorouracil.
    Brown MC
    Pharmacotherapy; 1997; 17(3):631-3. PubMed ID: 9165571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A patient with a prolonged prothrombin time due to an adverse interaction between 5-fluorouracil and warfarin.
    Aki Z; Kotiloğlu G; Ozyilkan O
    Am J Gastroenterol; 2000 Apr; 95(4):1093-4. PubMed ID: 10763974
    [No Abstract]   [Full Text] [Related]  

  • 16. Diarrhea-associated over-anticoagulation in a patient taking warfarin: therapeutic role of cholestyramine.
    Roberge RJ; Rao P; Miske GR; Riley TJ
    Vet Hum Toxicol; 2000 Dec; 42(6):351-3. PubMed ID: 11111942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 61-year-old man with sudden onset of gross hematuria: a case report.
    Kogan A; Aitchison R; Lees DS; Landoli CL; Dayrit K; Kharasch M; Wang E
    Am J Ther; 2014; 21(1):e7-8. PubMed ID: 23344100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epistaxis associated with elevation of INR in a patient switched to generic warfarin--a comment.
    Murphy JE
    Pharmacotherapy; 2000 Jul; 20(7):863-5; discussion 869-71. PubMed ID: 10907981
    [No Abstract]   [Full Text] [Related]  

  • 19. The risk of hemorrhage among patients with warfarin-associated coagulopathy.
    Garcia DA; Regan S; Crowther M; Hylek EM
    J Am Coll Cardiol; 2006 Feb; 47(4):804-8. PubMed ID: 16487849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The contribution of plasma (R)- & (S)-warfarin and vitamin K concentrations to intra-individual variability in anticoagulation.
    Kamali F; Edwards C; Butler TJ; Wynne HA
    Thromb Haemost; 2000 Feb; 83(2):349-50. PubMed ID: 10739399
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.